These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
408 related items for PubMed ID: 30154116
21. The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review. Ratten LK, Plummer EL, Bradshaw CS, Fairley CK, Murray GL, Garland SM, Bateson D, Tachedjian G, Masson L, Vodstrcil LA. Front Cell Infect Microbiol; 2021; 11():732423. PubMed ID: 34869054 [Abstract] [Full Text] [Related]
23. Depot medroxyprogesterone acetate (DMPA) enhances susceptibility and increases the window of vulnerability to HIV-1 in humanized mice. Wessels JM, Nguyen PV, Vitali D, Mueller K, Vahedi F, Felker AM, Dupont HA, Bagri P, Verschoor CP, Deshiere A, Mazzulli T, Tremblay MJ, Ashkar AA, Kaushic C. Sci Rep; 2021 Feb 16; 11(1):3894. PubMed ID: 33594113 [Abstract] [Full Text] [Related]
24. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. Doerflinger SY, Throop AL, Herbst-Kralovetz MM. J Infect Dis; 2014 Jun 15; 209(12):1989-99. PubMed ID: 24403560 [Abstract] [Full Text] [Related]
37. Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial. Bunjun R, Ramla TF, Jaumdally SZ, Noël-Romas L, Ayele H, Brown BP, Gamieldien H, Harryparsad R, Dabee S, Nair G, Onono M, Palanee-Phillips T, Scoville CW, Heller KB, Baeten JM, Bosinger SE, Burgener A, Passmore JS, Jaspan H, Heffron R. Clin Infect Dis; 2022 Nov 30; 75(11):2000-2011. PubMed ID: 35941737 [Abstract] [Full Text] [Related]
38. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. Mitchell CM, McLemore L, Westerberg K, Astronomo R, Smythe K, Gardella C, Mack M, Magaret A, Patton D, Agnew K, McElrath MJ, Hladik F, Eschenbach D. J Infect Dis; 2014 Aug 15; 210(4):651-5. PubMed ID: 24652495 [Abstract] [Full Text] [Related]
39. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. van de Wijgert JH, Verwijs MC, Turner AN, Morrison CS. AIDS; 2013 Aug 24; 27(13):2141-53. PubMed ID: 23660575 [Abstract] [Full Text] [Related]
40. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. Fichorova RN, Morrison CS, Chen PL, Yamamoto HS, Govender Y, Junaid D, Ryan S, Kwok C, Chipato T, Salata RA, Doncel GF. PLoS One; 2020 Aug 24; 15(1):e0224359. PubMed ID: 31914129 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]